Skip to content

Prevalence of breathlessness and its effect on quality of life in advanced cancer

Assessment of prevalence of dyspnoea in advanced cancer and its impact on quality of life: a prospective randomised study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/10/037194
Enrollment
500
Registered
2021-10-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C00-D49- Neoplasms

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. All patients with advanced cancer (stage IV diagnosis), referred for the first time to Department of Palliative Medicine 2. Age more than 18 years 3. Patient with normal cognitive status as determined by the physician and by her/his ability to understand the nature of the study and provide consent for the process 4. Patient willing to participate in the study and sign informed consent

Exclusion criteria

Exclusion criteria: 1. Patients unable to give consent due to impaired cognition, moribund state and acute medical illness 2. Those who refuse to participate in the study

Design outcomes

Primary

MeasureTime frame
Primary outcome of the study is determining the prevalence of dyspnoea in advanced cancer and to describe the correlation between the intensity of dyspnoea and the QOL of patients.The primary outcome measures used are intensity of dyspnoea as per ESAS, Cancer Dyspnoea Scale, and EORTC QLQ-C15-pal Questionnaires.Timepoint: over a period of six months from the date of first enrollment

Secondary

MeasureTime frame
The secondary outcome measures used are the demographic details of the participant, numerical rating of symptoms as per ESAS, intensity and perception of dyspnoea as per the Cancer Dyspnoea Scale, ECOG scale for functional status.Timepoint: over a period of six months from the date of first enrollment

Countries

India

Contacts

Public ContactM A Muckaden

Junior Resident, Dept of Palliative Medicine, Tata Memorial Hospital, Mumbai

anuja.damani@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026